Full Length Research Paper
References
Antley PP, Hazen KC (1988). Role of yeast cell growth temperature on Candida albicans virulence in mice. Infect. Immun. 56:2884-2890. Pubmed |
||||
Beck-Sague C, Banerjee S, Jarvis WR (1993). Infectious diseases and mortality among US nursing home residents. Am. J. Public Health. 83:1739-1742. Crossref |
||||
Calderone RA, Fonzi WA (2001). Virulence factors of Candida albicans. Trends Microbiol. 9:327-335. Crossref |
||||
Degterev A, Boyce M, Yuan J (2003). A decade of caspases. Oncogene. 22:8543-8567. Crossref |
||||
Enenkel C, Wolf DH (1993). BLH1 codes for a yeast thiol aminopeptidase, the equivalent of mammalian bleomycin hydrolase. J. Biol. Chem. 268:7036-7043. Pubmed |
||||
Ferrando AA, Velasco G, Campo E, Lopez-Otin C (1996). Cloning and expression analysis of human bleomycin hydrolase, a cysteine proteinase involved in chemotherapy resistance. Cancer Res. 56: 1746-1750. Pubmed |
||||
Garcia-Prieto F, Gomez-Raja J, Andaluz E, Calderone R, Larriba G (2010). Role of the homologous recombination genes RAD51 and RAD59 in the resistance of Candida albicans to UV light, radiomimetic and anti-tumor compounds and oxidizing agents. Fungal Genet. Biol. 47:433-445. Crossref |
||||
Hube B (2004). From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr. Opin. Microbiol. 7:336-341. Crossref |
||||
Ito H, Fukuda Y, Murata K, Kimura A (1983). Transformation of intact yeast cells treated with alkali cations. J. Bacteriol. 153:163-168. Pubmed |
||||
Jayaguru P, Raghunathan M (2007). Group I intron renders differential susceptibility of Candida albicans to Bleomycin. Mol. Biol. Rep. 34:11-17. Crossref |
||||
Joshua-Tor L, Xu HE, Johnston SA, Rees DC (1995). Crystal structure of a conserved protease that binds DNA: the bleomycin hydrolase, Gal6. Science. 269:945-950. Crossref |
||||
Kamata Y, Yamamoto M, Kawakami F, Tsuboi R, Takeda A, Ishihara K, Hibino T (2011). Bleomycin hydrolase is regulated biphasically in a differentiation- and cytokine-dependent manner: relevance to atopic dermatitis. J. Biol. Chem. 286:8204-8212. Crossref |
||||
Kambouris NG, Burke DJ, Creutz CE (1992). Cloning and characterization of a cysteine proteinase from Saccharomyces cerevisiae. J. Biol. Chem. 267:21570-21576. Pubmed |
||||
Kim B, Little JW (1993). LexA and lambda Cl repressors as enzymes: specific cleavage in an intermolecular reaction. Cell. 73:1165-1173. Crossref |
||||
Koldamova RP, Lefterov IM, DiSabella MT, Lazo JS (1998). An evolutionarily conserved cysteine protease, human bleomycin hydrolase, binds to the human homologue of ubiquitin-conjugating enzyme 9. Mol. Pharmacol. 54:954-961. Pubmed |
||||
Lan CY, Rodarte G, Murillo LA, et al. (2004). Regulatory networks affected by iron availability in Candida albicans. Mol. Microbiol. 53:1451-1469. Crossref |
||||
Lazo JS (1999). Bleomycin. Cancer Chemother. Biol. Response Modif. 18:39-45. Pubmed |
||||
Lazo JS, Braun ID, Labaree DC, Schisselbauer JC, Meandzija B, Newman RA, Kennedy KA (1989). Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin. Cancer Res. 49:185-190. Pubmed |
||||
Montoya SE, Aston CE, DeKosky ST, Kamboh MI, Lazo JS, Ferrell RE (1998). Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat. Genet. 18:211-212. Crossref |
||||
Montoya SE, Thiels E, Card JP, Lazo JS (2007). Astrogliosis and behavioral changes in mice lacking the neutral cysteine protease bleomycin hydrolase. Neuroscience. 146:890-900. Crossref |
||||
Muhlschlegal F, Fonzi W, Hoyer L, Payne T, Poulet FM, Clevenger J, Latge JP, Calera J, Beauvais A, Paris S, Monod M, Sturtevant J, Ghannoum M, Nozawa Y, Calderone R (1998). Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicans. Med. Mycol. 36 Suppl 1:238-248. Pubmed |
||||
Pei Z, Calmels TP, Creutz CE, Sebti SM (1995). Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells. Mol. Pharmacol. 48:676-681. Pubmed |
||||
Pfaller MA (1989). Infection control: opportunistic fungal infections--the increasing importance of Candida species. Infect. Control. Hosp. Epidemiol. 10:270-273. Crossref |
||||
Schwartz DR, Homanics GE, Hoyt DG, Klein E, Abernethy J, Lazo JS (1999). The neutral cysteine protease bleomycin hydrolase is essential for epidermal integrity and bleomycin resistance. Proc. Natl. Acad. Sci. USA 96:4680-4685. Crossref |
||||
Sebti SM, DeLeon JC, Lazo JS (1987). Purification, characterization, and amino acid composition of rabbit pulmonary bleomycin hydrolase. Biochemistry. 26:4213-4219. Crossref |
||||
Sebti SM, DeLeon JC, Ma LT, Hecht SM, Lazo JS (1989). Substrate specificity of bleomycin hydrolase. Biochem. Pharmacol. 38:141-147. Crossref |
||||
Sebti SM, Lazo JS (1987). Separation of the protective enzyme bleomycin hydrolase from rabbit pulmonary aminopeptidases. Biochemistry. 26:432-437. Crossref |
||||
Sebti SM, Mignano JE, Jani JP, Srimatkandada S, Lazo JS (1989). Bleomycin hydrolase: molecular cloning, sequencing, and biochemical studies reveal membership in the cysteine proteinase family. Biochemistry. 28:6544-6548. Crossref |
||||
Takeda A, Masuda Y, Yamamoto T, Hirabayashi T, Nakamura Y, Nakaya K (1996). Cloning and analysis of cDNA encoding rat bleomycin hydrolase, a DNA-binding cysteine protease. J. Biochem. 120:353-359. Crossref |
||||
Trumbly RJ, Bradley G (1983). Isolation and characterization of aminopeptidase mutants of Saccharomyces cerevisiae. J. Bacteriol. 156:36-48. Pubmed |
||||
Wang H, Ramotar D (2002). Cellular resistance to bleomycin in Saccharomyces cerevisiae is not affected by changes in bleomycin hydrolase levels. Biochem. Cell. Biol. 80:789-796. Crossref |
||||
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988). Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645. Crossref |
||||
Xu HE, Johnston SA (1994). Yeast bleomycin hydrolase is a DNA-binding cysteine protease. Identification, purification, biochemical characterization. J. Biol. Chem. 269:21177-21183. Pubmed |
||||
Zheng W, Johnston SA (1998). The nucleic acid binding activity of bleomycin hydrolase is involved in bleomycin detoxification. Mol. Cell. Biol. 18:3580-3585. Pubmed |
||||
Zheng W, Johnston SA, Joshua-Tor L (1998). The unusual active site of Gal6/bleomycin hydrolase can act as a carboxypeptidase, aminopeptidase, and peptide ligase. Cell 93:103-109. Crossref |
||||
Zheng W, Xu HE, Johnston SA (1997). The cysteine-peptidase bleomycin hydrolase is a member of the galactose regulon in yeast. J. Biol. Chem. 272:30350-30355. Crossref |
||||
Zimny J, Sikora M, Guranowski A, Jakubowski H (2006). Protective mechanisms against homocysteine toxicity: the role of bleomycin hydrolase. J. Biol. Chem. 281:22485-22492. Crossref |
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0